so they have dosed 4 patients at the lowest dose. And nothing went wrong. I would say the price wont go down,but honestly cant see why it would go up. It might go up if these 4 patients fail to progress with their cancer over the next 4 or so months, but that takes imaging and clinical input, but also 4 months.
Ann: Successful Completion of Dosing in First Patient Cohort, page-6
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
-0.001(16.7%) |
Mkt cap ! $10.07M | |||
| Open | High | Low | Value | Volume |
| 0.6¢ | 0.6¢ | 0.5¢ | $48.20K | 9.498M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2822655 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.6¢ | 12369767 | 16 |
View Market Depth
| Last trade - 15.01pm 18/07/2025 (20 minute delay) ? |
| CHM (ASX) Chart |